Abstract
One of the oldest and most commonly used procedures in biological research to elucidate the physiological significance of an organ is its destruction or functional elimination. This principle has found wide application in the investigation of the physiological role of endocrine glands, in the characterization of the coordinative and regulatory function of different centres and tracts of the central nervous system and also in the study of the peripheral nervous system. Particularly for the sympathetic nervous system this procedure has proved to be most important in the elucidation of its general homeostatic function (Cannon et al., 1929; Sawyer et al., 1933; Cannon and Rosenblueth, 1937) and in the more detailed investigations concerning the sites of synthesis, storage and enzymatic degradation of the adrenergic transmitter (Von Euler and Purkhold, 1951; Goodall, 1951; BURN et al., 1954; CROUT and Cooper, 1962; Anden et al., 1964; Waltman and Sears, 1964; Hertting, 1965; Klingman, 1965; Potter et al., 1965; Iversen et al., 1966, 1968; Sedvall and Kopin, 1967; Mueller et al., 1969; Nagatsu et al., 1969). Moreover, denervation experiments have been of crucial importance in detecting that uptake into the adrenergic nerve terminals is generally the main mechanism by which exogenously administered or neurally liberated noradrenaline is inactivated (Hertting et al., 1961a; Hertting and Schiefthaler, 1964; Hertting, 1965; Potter et al., 1965) and that the activity of the adrenergic neurons beyond their actual effect have also “trophic” actions on the effector organs (BURN, 1952; Trendelenburg and Weiner, 1962; Fleming, 1963; Trendelenburg, 1963a, b).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahlquist, E.P.: A study of adrenotropic receptors. Amer. J. Physiol. 153, 586–600 (1948).
Andén, N.E., Magnttsson, T., Rosengren, E.: On the presence of dihydroxyphenylalaninedecarboxylase in nerves. Experientia (Basel) 20, 328–329 (1964).
Anderson, H.K.: The paralysis of involuntary muscle, with special reference to the occurrence of paradoxical contraction. Part I. Paradoxical pupil-dilatation and other ocular phenomena caused by lesions of the cervical sympathetic tract. J. Physiol. (Lond.) 30, 290–310 (1904).
Angeletti, P., Calissano, P., Chen, J.S., Levi-Montalcini, R.: Multiple molecular forms of the nerve growth factor. Biochim. biophys. Acta (Amst.) 147, 180–182 (1967).
Axelrod, J., Albers, W., Clemente, C.D.: Distribution of catechol-0-methyl transferase in the nervous system and other tissues. J. Neurochem. 5, 68–72 (1959a).
Axelrod, J., Hertting, G., Potter, L.: Effect of drugs on the uptake and release of H3-norepinephrine in the rat heart. Nature (Lond.) 194, 297 (1962).
Axelrod, J., Laroche, M.J.: Inhibitor of O-methylation of epinephrine and norepinephrine in vitro and in vivo. Science 130, 800 (1959).
Axelrod, J., Shein, H.M., Wurtman, R.J.: Stimulation of C14-melatonin synthesis from ß-tryptophan by noradrenaline in rat pineal in organ culture. Proc. nat. Acad. Sci. (Wash.) 62, 544–549 (1969).
Axelrod, J., Weil-Malherbe, H., Tomchick, R.: The physiological disposition of H3-epinephrine and its metabolite metanephrine. J. Pharmacol, exp. Ther. 127, 251–256 (1959b).
Axelsson, J., Thesleff, S.: A study of supersensitivity in denervated mammalian skeletal muscle. J. Physiol. (Lond.) 147, 178–193 (1959).
Bacq, Z.M., Gosselin, L., Dresse, A., Renson, J.: Inhibition of 0-methyl-transferase by catechol and sensitization to epinephrine. Science 130, 453–454 (1959).
Barany, E.H., Treister, G.: Time relations of degeneration mydriasis and degeneration vasoconstriction in the rabbit ear after sympathetic denervation. Effect of bretylium. Acta physiol. scand. (in press).
Belleau, B., Burba, J.: Tropolones: a unique class of potent non-competitive inhibitors of S-adenosylmethionine-catechol methyltransferase. Biochim. biophys. Acta (Amst.) 54, 195–196 (1961).
Benmiloud, M., Eijler, U.S. V.: Effects of bretylium, reserpine, guanethidine and sympathetic denervation on the noradrenaline content of the rat submaxillary gland. Acta physiol. scand. 59, 34–42 (1963).
Bhagat, B.: Effect of noradrenaline injection on the catecholamine content of the rat heart. Arch. int. Pharmacodyn. 146, 47–55 (1963).
Biel, J.H., Lum, B.K.B.: The ß-adrenergic blocking agents. Pharmacology and structureactivity relationships. Fortschr. Arzneimittelforsch. 10, 46–89 (1966).
Birmingham, A.T.: Denervation of the vas deferens of the guinea-pig. J. Physiol. (Lond.) 190, 16P–17P (1967).
Birmingham, A.T.: Post-Ganglionic Denervation Of The Rat Vas Deferens. J. Physiol. (Lond.) 197, 37P–38P (1968).
Bloom, F., Groppetti, A., Revuelta, A., Costa, E.: Biochemical and fine structural effects of 6-hydroxydopamine on rat central nervous system after intracisternal injection. 4th Int. Congr. Pharmac. Abstr. 218–219 (1969).
Boura, A.L.A., Green, A.F.: The actions of bretylium: adrenergic neurone blocking and other effects. Brit. J. Pharmacol. 14, 536–548 (1959).
Brody, M.J.: Cardiovascular responses following immunological sympathectomy. Circulat. Res. 15, 161–167 (1964).
Brown, G.L., Davies, B.M., Ferry, C.B.: The effect of neuronal rest on the output of sympathetic transmitter from the spleen. J. Physiol. (Lond.) 159, 365–380 (1961).
Bijdge, J.L.: Über die Bewegung der Iris; für Physiologen und Ärzte. Braunschweig: Vieweg 1855.BUEKER, E. D.: Implantation of tumors in the hind limb field of the embryonic chick and developmental response of the lumbosacral nervous system. Anat. Ree. 102, 369–390 (1948).
Burkard, W.P., Gey, K.F., Pletscher, A.: Inhibition of decarboxylase of aromatic amino acids by 2,3,4-trihydroxybenzylhydrazine and its seryl derivatives. Arch. Biochem. 107, 187–196 (1964).
Burkard, W.P., Jalfre, M., Blum, J.: Effect of 6-hydroxydopamine on behaviour and cerebral amine in rats. Experientia (Basel) 25, 1295–1296 (1969).
Burn, J.H.: Practical pharmacology. Oxford: Blackwell 1952.
Burn, J.H.: Functions Of Autonomic Transmitters. Baltimore: The Williams and Wilkins Co. 1956.
Burn, J.H., Philpot, F. J., Trendelenburg, U. V.: Effect of denervation on enzymes in iris and blood vessels. Brit. J. Pharmacol. 9, 423–428 (1954).
Burn, J.H., Robinson, J.: Hypersensitivity of the denervated nictitating membrane and amine oxidase. J. Physiol. (Lond.) 120, 224–229 (1953).
Cannon, W.B., Lissak, K.: Evidence for adrenaline in adrenergic neurones. Amer. J. Physiol. 125, 765–777 (1939).
Cannon, W.B., Newton, H.F., Bright, E.M., Menkin, V., Moore, R.M.: Some aspects of the physiology of animals surviving complete exclusion of sympathetic nerve impulses. Amer. J. Physiol. 89, 84–107 (1929).
Cannon, W.B., Rosenblueth, A.: Autonomic neuro-effector systems. New York: The MacMillan Co. 1937.
Cannon, W.B., Rosenblueth, A.:The Supersensitivity Of Denervated Structures. A Law Of Denervation. New York: TheMacMillan Co. 1949.
Carlsson, A., Rosengren, E., Bertler, A., Nilsson, J.: The effect of reserpine on the metabolism of catecholamines. In: S. Garattini And V. Ghetti: Psychotropic drugs, pp. 363–372. Amsterdam: Elsevier 1957.
Referencescarpi, A., Oliverio, A.: Urinary excretion of catecholamines in the immunosympathectomiz-ed rat–Balance phenomena between the adrenergic and the noradrenergic system. Int. J. Neuropharmacol. 3, 427–431 (1964).
Cervoni, P.: Monoamine oxidase activity of the cat nictitating membrane and superior cervical ganglion under various experimental conditions. Biochem. Pharmacol. 18, 1427–1433 (1969).
Clarke, D.E., Jones, C.J.: Are adrenergic nerves required for uptake2 in the isolated perfused rat heart? Europ. J. Pharmacol. 7, 121–124 (1969).
Clarke, D.E., Linley, P.A.: Histochemical fluorescence studies on noradrenaline accumulation byuptake2 in the isolated rat heart. Brit. J. Pharmacol. 34, 1–9 (1969).
Coats, D.A., Emmelin, N.: The short-term effects of sympathetic ganglionectomy on the cat’s salivary secretion. J. Physiol. (Lond.) 162, 282–288 (1962).
Cohen, S.: A nerve growth-promoting protein. In: W.D. Mcelroy And B. Glass: Basis of development, pp. 665–667. Baltimore: Johns Hopkins Press 1958.
Cohen, S.: Purification And Metabolic Effects Of A Nerve Growth-Promoting Protein From Snake Venom. J. Biol. Chem. 234, 1129–1137 (1959).
Cohen, S.: Purification Of A Nerve-Growth Promoting Protein From The Mouse Salivary Gland And Its Neuro-Cytotoxic Antiserum. Proc. Nat. Acad. Sci. (Wash.) 46, 302–311 (1960).
Cooper, T.: Surgical sympathectomy and adrenergic function. Pharmacol. Rev. 18, 611–618 (1966).
Cooper, T., Gilbert, J.W., Bloodwell, R.D., Crout, J.R.: Chronic extrinsic cardiac denervation by regional neural ablation: Description of the operation, verification of the denervation and its effects on myocardial catecholamines. Circulat. Res. 9, 275–281 (1961).
Cooper, T., Gilbert, J.W., Bloodwell, R.D., Crout, J.R., Sjoerdsma, A.: Depletion of splenic norepinephrine in rat by celiac ganglionectomy. Proc. Soc. exp. Biol. (N.Y.) 109, 538–539 (1962).
Cooper, T., Willman, V.L., Jellinek, M., Hanlon, C.R.: Heart autotransplantation: Effect on myocardial catecholamines and histamine. Science 138, 40–41 (1962).
Crain, S.M., Benitz, H., Vatter, A.E.: Some cytologic effects of salivary nerve-growth factor on tissue cultures of peripheral ganglia. Ann. N.Y. Acad. Sci. 118, 206–231 (1964).
Crout, J.R., Cooper, T.: Myocardial catechol-O-methyl transferase activity after chronic cardiac denervation. Nature (Lond.) 194, 387 (1962).
Dahlström, A., Fuxe, K.: Evidence for the existence of monoamine neurons in the central nervous system. Acta physiol. scand. 64, Suppl. 247 (1965).
Dahlström, A., Häggendal, J.: Studies on the transport and lifespan of amine storage granules in a peripheral adrenergic neuron system. Acta physiol. scand. 67, 278–288 (1966).
De Castro, F.: Die normale Histologie des peripheren vegetativen Nervensystems. Das Synapsen-Problem: Anatomisch-experimentelle Untersuchungen. Yerh. dtsch. path. Ges. 34, 1–52 (1950).
De La Lande, I.S., Frewin, D., Waterson, J.G.: The influence of sympathetic innervation on vascular sensitivity to noradrenaline. Brit. J. Pharmacol. 31, 82–93 (1967).
Dempsey, P. J., Cooper, T.: Supersensitivity of the chronically denervated feline heart. Amer. J. Physiol. 215, 1245–1249 (1968).
De Vine, C.E.: The fine structure of vascular axons after treatment with 6-hydroxydopamine. Proc. Univ. Otago med. Sch. 47, 4–6 (1969).
Elliott, T. R.: The action of adrenaline. J. Physiol. (Lond.) 32, 401–467 (1905).
Euler, U.S. V., Purkhold, A.: Effect of sympathetic denervation on the noradrenaline and adrenaline content of the spleen, kidney, and salivary glands in the sheep. Acta physiol. scand. 24, 212–217 (1951).
Falck, B.: Observations on the possibilities of the cellular localization of monoamines by a fluorescence method. Acta physiol. scand. 56, Suppl. 197 (1962).
Falck, B., Hillarp, N.-Ä., Thieme, G., Torp, A.: Fluorescence of catecholamines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 10, 348–354 (1962).
Finch, L., Leach, G.D.H.: A comparison of the effects of 6-hydroxydopamine immunosympathectomy and reserpine on the cardiovascular reactivity in the rat. J. Pharm. Pharmacol. 22, 354–360 (1970).
Fischer, J.E., Kopin, I.J., Axelrod, J.: Evidence for extraneuronal binding of norepine-phrine. J. Pharmacol, exp. Ther. 147, 181–185 (1965).
Fischer, J.E., Musacchio, J., Kopin, I. J., Axelrod, J.: Effects of denervation on the uptake and ß-hydroxylation of tyramine in the rat salivary gland. Life Sci. 3, 413–419 (1964).
Fischer, J.E., Snyder, S.: Disposition of norepinephrine-H3 in sympathetic ganglia. J. Pharmacol, exp. Ther. 150, 190–195 (1965).
Fleckenstein, A., Bass, H.: Zum Mechanismus der Wirkungsverstärkung und Wirkungsabschwächung sympathomimetischer Amine durch Cocain und andere Pharmaka. I. Mitteilung: Die Sensibilisierung der Katzen-Nickhaut für Sympathomimetica der Brenzkatechin-Reihe. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 220, 143–156 (1953).
Fleming, W. W.: A comparative study of supersensitivity to norepinephrine and acetylcholine produced by denervation, decentralization and reserpine. J. Pharmacol, exp. Ther. 141, 173–179 (1963).
Fleming, W. W., Trendelenburg, U.: The development of supersensitivity to norepinephrine after pretreatment with reserpine. J. Pharmacol, exp. Ther. 133, 41–51 (1961).
Furchgott, R.F.: The receptors for epinephrine and norepinephrine (adrenergic receptors). Pharmacol. Rev. 11, 429–441 (1959).
Fuxe, K., Sedvall, G.: The distribution of adrenergic nerve fibres to the blood vessels in skeletal muscle. Acta physiol. scand. 64, 75–86 (1965).
Geffen, L.B., Ostberg, A.: Distribution of granular vesicles in normal and constricted sympathetic neurones. J. Physiol. (Lond.) 204, 583–592 (1969).
Gillespie, J.S., Munt, T.C.: A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. Brit. J. Pharmacol. 30, 78–87 (1967).
Glowinski, J., Axelrod, J., Kopin, I. J., Wurtman, R.J.: Physiological disposition of H3norepinephrine in the developing rat. J. Pharmacol, exp. Ther. 146, 48–53 (1964).
Goldstein, M., Anagnoste, B., Lauber, E., Mckereghan, M. R.: Inhibition of dopamines-hydroxylase by disulfiram. Life Sci. 3, 763–767 (1964).
Goodall, Mc. C.: Studies of adrenaline and noradrenaline in mammalian heart and suprarenals. Acta physiol. scand. 24, Suppl. 85 (1951).
Goodall, Mc. C., Kirshner, N.: Eifect of cervico-thoracic ganglionectomy on the adrenaline and noradrenaline content of the mammalian heart. J. clin. Invest. 35, 649–656 (1956).
Green III, R.D., Fleming, W.W.: Agonist-antagonist interactions in the normal and supersensitive nictitating membrane of the spinal cat. J. Pharmacol, exp. Ther. 156, 207–214 (1967).
Green III, R.D., Fleming, W.W.: Analysis Of Supersensitivity In The Isolated Spleen Of The Cat. J. Pharmacol, Exp. Ther. 162, 254–262 (1968).
Haefely, W., Huerlimann, A., Thoenen, H.: A quantitative study of the eifect of cocaine on the response of the cat nictitating membrane to nerve stimulation and to injected noradrenaline. Brit. J. Pharmacol. 22, 5–21 (1964).
Haeusler, G., Haefely, W., Huerlimann, A.: Effect of surgical and chemical adrenergic denervation on vascular responses. Proc. Symp. Physiol. Pharmacol. Vase. Neuroeffector System, Interlaken 1969, pp. 141–159. Basel: Karger 1971.
Haeusler, G., Thoenen, H.: Chemical sympathectomy of the cat with 6-hydroxydopamine. J. Pharmacol. exp. Ther. 170, 50–61 (1969).
Haeusler, G., Thoenen, H., Haefely, W.: Chemische Sympathektomie der Katze mit 6-Hydroxydopamin: Veränderungen von Sympathicusreizeffekten und Noradrenalinempfindlichkeit. Helv. physiol. pharmacol. Acta 26, CR 223–225 (1968).
Häkanson, R., Owman, Ch.: Effect of denervation and enzyme inhibition on DOPA decarboxylase and monoamine oxidase activities of rat pineal gland. J. Neurochem. 12, 417–429 (1965).
Hamberger, B., Levi-Montalcini, R., Norberg, K.A., Sjöqvist, F.: Monoamines in immu-nosympathectomized rats. Int. J. Neuropharmacol. 4, 91–95 (1965).
Hennemann, H.-M., Trendelenburg, U.: Effect of the adrenergic neurone blocker ß-TM10, on the depletion of noradrenaline induced by denervation or reserpine. Naunyn-Schmiede-berg’s Arch. Pharmak. 265, 363–371 (1970).
Hertting, G.: The fate of 3H-iso-proterenol in the rat. Biochem. Pharmacol. 13, 1119–1128 (1964).
Hertting, G.: Effect Of Drugs And Sympathetic Denervation On Noradrenaline Uptake And Binding In Animal Tissues. In: G.B. Koelle, W.W. Douglas, And A. Carlsson: Pharmacology of cholinergic and adrenergic transmission, pp. 277–288. Oxford: Pergamon Press 1965.
Hertting, G., Axelrod, J., Kopin, I. J., Whitby, L.G.: Lack of uptake of catecholamines after chronic denervation of sympathetic nerves. Nature (Lond.) 189, 66 (1961a).
Hertting, G., Patrick, R.W.: Actions of bretylium and guanethidine on the uptake and release of 3H-noradrenaline. Brit. J. Pharmacol. 18, 161–166 (1962).
Hertting, G., Whitby, L. G.: Effect of drugs on the uptake and metabolism of 3H-norepinephrine. J. Pharmacol, exp. Ther. 134, 146–153 (1961b).
Hertting, G., Schiefthaler, T.: The effect of stellate ganglion excision on the catecholamine content and the uptake of H3-norepinephrine in the heart of the cat. Int. J. Neuropharmacol. 3, 65–69 (1964).
Hertting, G., Suko, J., Widhalm, S., Harbich, I.: Über den Mechanismus der Potenzierung der Katecholaminwirkung nach chronisch postganglionärer sympathischer Denervierung. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 256, 40–54 (1967).
Hillarp, N.-Ä.: Structure of the synapse and the peripheral innervation apparatus of the autonomic nervous system, Acta anat. (Basel) 2, Suppl. I V (1946).
Holzbaues, M., Vogt, M.: Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. J. Neurochem. 1, 8–11 (1956).
Hukoviö, S., Muscholl, E.: Die Noradrenalin-Abgabe aus dem isolierten Kaninchenherzen bei sympathischer Nervenreizung und ihre pharmakologische Beeinflussung. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 244, 81–96 (1962).
Innes, I.R., Kosteblitz, H.W.: The effects of preganglionic and postganglionic denervation on the responses of the nictitating membrane to sympathomimetic substances. J. Physiol. (Lond.) 124, 25–43 (1954).
Iversen, L.L.: The inhibition of noradrenaline uptake by drugs. In: N.J. Harper And A.B. Simmonds: Advances Drug Res. 2, pp. 1–46. London: Academic Press 1965.
Iversen, L.L.: The Uptake And Storage Of Noradrenaline In Sympathetic Nerves. Cambridge: University Press 1967.
Iversen, L.L., Glowinski, J., Axelrod, J.: The physiologic disposition and metabolism of norepine-phrine in immunosympathectomized animals. J. Pharmacol, exp. Ther. 151, 273–284 (1966).
Iversen, L.L., Jarrott, B., Langer, S.Z.: Monoamine oxidase and catechol-O-methyl transferase activities in cat nictitating membrane and rat and guinea pig vas deferens after sympathectomy. Brit. J. Pharmacol. 34, 693P–694P (1968).
Jonason, J.: Metabolism of dopamine and noradrenaline in normal atrophied and postganglionically sympathectomized rat salivary glands in vitro. Acta physiol. scand. 76, 299–311 (1969).
Kapeller, K., Mayor, D.: The accumulation of noradrenaline in constricted sympathetic nerves as studied by fluorescence and electron microscopy. Proc. roy. Soc. B. 167, 282–292 (1967).
Kapeller, K., Mayor, D.:An Electron Microscopic Study Of The Early Changes Proximal To A Constriction In Sympathetic Nerves. Proc. Roy. Soc. B. 172, 39–51 (1969).
Kirpekar, S.M., Cervoni, P., Fttrchgott, R.F.: Catecholamine content of the cat nictitating membrane following procedures sensitizing it to norepinephrine. J. Pharmacol, exp. Ther. 135, 180–190 (1962).
Klingman, G.I.: Catecholamine levels and dopa-decarboxylase activity in peripheral organs and adrenergic tissues in the rat after immunosympathectomy. J. Pharmacol. (Lond.) 148, 14–21 (1965).
Klingman, G.I.: 5-Hydroxytryptamine Levels In Peripheral Organs Of Immunosympathectomized Rats. Biochem. Pharmacol. 18, 2061–2067 (1969).
Klingman, G.I., Klingman, J.D.: Catecholamines in peripheral tissues of mice and cell counts of sympathetic ganglia after the prenatal and postnatal administration of the nerve growth factor antiserum. Int. J. Neuropharmacol. 6, 501–508 (1967).
Klingman, G.I., Klingman, J.D.: Effect Of Sympathetic Denervation On The 5-Hydroxytryptamine Levels Of The Submaxillary Glands Of Rats. Biochem. Pharmacol. 18, 2069–2074 (1969).
Kopin, I. J., Gordon, E.K., Horst, W.D.: Studies of uptake of 1-norepinephrine–14 Biochem. Pharmacol. 14, 753–759 (1965).
Langendorff, O.: Zur Deutung der „paradoxen” Pupillenerweiterung. Klin. Mbl. Augen-heilk. 38, 823–827 (1900).
Langer, S. Z.: The degeneration contraction of the nictitating membrane in the unanesthetized cat. J. Pharmacol, exp. Ther. 151, 66–72 (1966).
Langer, S. Z., Drasköczy, P.R., Trendelenburg, U.: Time course of the development of supersensitivity to various amines in the nictitating membrane of the pithed cat after denervation or decentralization. J. Pharmacol, exp. Ther. 157, 255–273 (1967).
Langer, S. Z., Trendelenburg, U.: The onset of denervation supersensitivity. J. Pharmacol, exp. Ther. 151, 73–86 (1966).
Laverty, R., Phelan, E.L.: Effects of 6-hydroxydopamine on noradrenaline storage and uptake in the rat. Proc. Univ. Otago med. Sch. 47, 18–19 (1969).
Laverty, R., Sharman, D.F., Vogt, M.: Action of 2,4,5-trihydroxyphenylethylamine on the storage and release of noradrenaline. Brit. J. Pharmacol. 24, 549–560 (1965).
Lawrenuew, B.I.: Über die Erscheinung der Degeneration und Regeneration im sympathischen Nervensystem. Z. mikr.-anat. Forsch. 2, 201–223 (1925).
Lawrenuew, B.I., Borowskaja, A.J.: Die Degeneration der postganglionären Fasern des autonomen Nervensystems und deren Endigungen. Z. Zellforsch. Abt. Histochem. 23, 761–796 (1935).
Lever, J.D., Esterhuizen, A.C.: Fine structure of the arteriolar nerves in the guinea pig pancreas. Nature (Lond.) 192, 566–567 (1961).
Levi-Montalcini, R.: Chemical stimulation of nerve growth. In: W.D. Mcelroy And B. Glass: Chemical basis of development, pp. 646–664. Baltimore: Johns Hopkins Press 1958.
Leyi-Montalcini, R.: The nerve growth factor: its mode of action on sensory and sympathetic nerve cells. Harvey Lect. 60, 217–259 (1966).
Leyi-Montalcini, R.: Differentiation And Growth Control Mechanisms In The Nervous Systems. In: E. Hagen, W. Wechsler, And P. Zilliken: Experimental biology and medicine. Morphological and biochemical aspects of cytodifferentiation, vol. 1, pp. 170–182. Basel: Karger 1967.
Leyi-Montalcini, R., Angeletti, P.U.: Noradrenaline and monoaminoxidase content in immunosympathectomized animals. Int. J. Neuropharmacol. 1, 161–164 (1962).
Leyi-Montalcini, R., Angeletti, P.U.: Immunosympathectomy. Pharmacol. Rev. 18, 619–628 (1966).
Leyi-Montalcini, R., Angeletti, P.U.: Nerve Growth Factor. Physiol. Rev. 48, 534–569 (1968).
Leyi-Montalcini, R., Bookeb, B.: Destruction of sympathetic ganglia in mammals by antiserum to a nervegrowth protein. Proc. nat. Acad. Sci. (Wash.) 42, 384–391 (1960).
Leyi-Montalcini, R., Cohen, S.: In vitro and in vivo effects of a nerve growth-stimulating agent isolated from snake venom. Proc. nat. Acad. Sci. (Wash.) 42, 695–699 (1956).
Leyi-Montalcini, R., Cohen, S.: Effects Of The Extract Of The Mouse Submaxillary Salivary Glands On The Sympatheticsystem Of Mammals. Ann. N.Y. Acad. Sci. 85, 324–341 (1960).
Leyi-Montalcini, R., Hamburger, V.: Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J. exp. Zool. 116, 321–361 (1951).
Leyi-Montalcini, R., Meyer, H., Hamburger, V.: In vitro experiments on the effects of mouse sarcomas 180 and 37 on the spinal and sympathetic ganglia of the chick embryo. Cancer Res. 14, 49–57 (1954).
Leyi-Montalcini, R., Tentori, L., Vivaldi, G., Angeletti, P.U., Marini-Bettolo, G.B.: Composizione in amino acidi del fattore di crescita del sistema nervoso (NGF). Gazz. chim. ital. 95, 333–337 (1965).
Levitt, M., Spector, S., Sjoerdsma, A., Udenfriend, S.: Elucidation of the ratelimiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J. Pharmacol, exp. Ther. 148, 1–8 (1965).
Lovenberg, W., Barchas, J., Weissbach, H., Udenfriend, S.: Characteristics of the inhibition of aromatic L-amino acid decarboxylase by α-methylamino acids. Arch. Biochem. 103, 9–14 (1963).
Lundberg, D.: Adrenergic neuron blockers and transmitter release after sympathetic denervation studied in the conscious rat. Acta physiol. scand. 75, 415–426 (1969).
Maickel, R.P., Matussek, N., Stern, D.N., Brodie, B.B.: The sympathetic nervous system as a homeostatic mechanism. I. Absolute need for sympathetic nervous function in body temperature maintenance of cold-exposed rats. J. Pharmacol, exp. Ther. 157, 103–110 (1967).
Malmfors, T., Sachs, C.: Direct studies on the disappearance of the transmitter and changes in the uptake-storage mechanisms of degenerating adrenergic nerves. Acta physiol. scand. 64, 211–223 (1965).
Malmfors, T., Sachs, C.: Degeneration Of Adrenergic Nerves Produced By 6-Hydroxydopamine. Europ. J. Pharmacol. 3, 89–92 (1968).
Meltzer, S.J.: Studies on the “paradoxical” pupil-dilatation caused by adrenaline. II.–On the influence of subcutaneous injections of adrenaline upon the eyes of cats after removal of the superior cervical ganglion. Amer. J. Physiol. 11, 37–51 (1904).
Meltzer, S.J., Auer, C.M.: Studies on the “paradoxical” pupil-dilatation caused by adrenaline. I.–The effect of subcutaneous injections and instillations of adrenaline upon the pupils of rabbits. Amer. J. Physiol. 11, 28–36 (1904).
Miledi, R.: The acetylcholine sensitivity of frog muscle fibres after complete or partial denervation. J. Physiol. (Lond.) 151, 1–23 (1960).
Molinoff, P., Axelrod, J.: Octopamine: normal occurrence in sympathetic nerves of rats. Science 164, 428–429 (1969).
Moran, N.C., Perkins, M.E.: Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol. J. Pharmacol, exp. Ther. 124, 223–237 (1958).
Morrison, J.M., Jr., Fleming, W.W.: The non specific supersensitivity of the cat nictitating membrane. Pharmacologist 9, 234 (1967).
Mueller, R.A., Thoenen, H., Axelrod, J.: Adrenal tyrosine hydroxylase: compensatory increase in activity after chemical sympathectomy. Science 163, 468–469 (1969).
Muscholl, E.: Über den Wirkungsmechanismus von Reserpin. Klin. Wschr. 37, 217–226 (1959).
Muscholl, E.: Die Hemmung Der Noradrenalin-Aufnahme Des Herzens Durch Reserpin Und Die Wirkung Von Tyramin. Naunyn-Schmiedeberg’S Arch. Exp. Path. Pharmak. 240, 234–241 (1960).
Muscholl, E.: Effect Of Cocaine And Related Drugs On The Uptake Of Noradrenaline By Heart And Spleen. Brit. J. Pharmacol. 16, 352–359 (1961).
Nagatsu, T., Rust, L.A., Dequattro, V.: The activity of tyrosine hydroxylase and related enzymes of catecholamine biosynthesis and metabolism in dog kidney–effects of denervation. Biochem. Pharmacol. 18, 1441–1446 (1969).
Nickerson, M.: The pharmacology of adrenergic blockade. Pharmacol. Rev. 1, 27–101 (1949).
Pletscher, A., Brossi, A., Gey, K.F.: Benzoquinolizine derivatives, a new class of monoamine decreasing drugs with psychotropic action. Int. Rev. Neurobiol. 6, 275–306 (1962).
Pletscher, A., Gey, K.F., Zeller, P.: Monoaminoxydase-Hemmer. In: E. Jucker: Fortschr. Arzneimittelforsch. 2, 417–590 (1960).
Pluchino, S.: a-and ß-effects of isoproterenol (ISO) on the cat’s nictitating membrane. Pharmacologist 9, 248 (1967).
Pluchino, S., Trendelenburg, U.: The influence of denervation and of decentralization on the alpha and beta effects of isoproterenol on the nictitating membrane of the pithed cat. J. Pharmacol. exp. Ther. 163, 257–265 (1968).
Porter, C.C., Totaro, J.A., Burcin, A.: The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine. J. Pharmacol, exp. Ther. 150, 17–22 (1965).
Porter, C.C., Stoke, C.A.: Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice. J. Pharmacol, exp. Ther. 140, 308–316 (1963).
Potter, L.T., Cooper, T., Willman, V.L., Wolfe, D.E.: Synthesis, binding, release, and metabolism of norepinephrine in normal and transplanted dog hearts. Circulat. Res. 16, 468–481 (1965).
Powell, C.E., Slater, I.H.: Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. J. Pharmacol, exp. Ther. 122, 480–488 (1958).
Quilliam, J.P., Tamarin, D.L.: Ultrastructural changes in the superior cervical ganglion of the rat following preganglionic denervation. J. Physiol. (Lond.) 189, 13P–15P (1967).
Raab, W., Gigee, W.: Die Katecholamine des Herzens. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 219, 248–262 (1953).
Raab, W., Gigee, W.: Specific Avidity Of Heart Muscle To Absorb And Store Epinephrine And Norepinephrine.Circulat. Res. 3, 553–558 (1955).
Raab, W., Humphreys, R.J.: Drug action upon myocardial epinephrine-sympathin concentration and heart rate (nitroglycerine, papaverine, priscol, dibenamine-hydrochloride). J. Pharmacol. exp. Ther. 89, 64–76 (1947).
Rehn, N.O.: Effect of decentralisation on the content of catechol amines in the spleen and kidney of the cat. Acta physiol. scand. 42, 309–312 (1958).
Richardson, K.C.: The fine structure of the albino rabbit iris with special reference to the identification of adrenergic and cholinergic nerves and nerve endings in its intrinsic muscles. Amer. J. Anat. 114, 173–184 (1964).
Sabatini, M.T., Deiraldi, A.P., De Robertis, E.: Early effects of antiserum against the nerve growth factor on fine structure of sympathetic neurons. J. exp. Neurol. 12, 370–383 (1965).
Salvt, M.L., Angeletti, P.U., Frati, L.: Frazionamento delle proteine solubili della ghiandola sottomascellare del topo: localizzazione di alcune componenti biologicamente attive. II Farmaco 20, 12–21 (1965).
Saner, A., Thoenen, H.: Model experiments on the molecular mechanism of action of 6-hydroxydopamine. Molec. Pharmacol. 7, 147–154 (1971).
Sawyer, M.E., Mac, K., Schlossberg, T.: Studies of homeostasis in normal, sympathectomized and ergotaminized animals. Amer. J. Physiol. 104, 172–203 (1933).
Schenkein, I., Bueker, E.D.: Dialyzable cofactor in nerve growth promoting protein from mouse salivary glands. Science 137, 433–434 (1962).
Schenkein, I., Bueker, E.D.: The Nerve Growth Factor As Two Essential Components. Ann. N.Y. Acad. Sci. 118, 171–182 (1964).
Schmidt, J.L., Fleming, W.W.: Supersensitivity to barium in the denervated nictitating membrane of the spinal cat. Proc. Soc. exp. Biol. (N.Y.) 117, 302–303 (1964).
Sears, M.L., Barany, E.H.: Outflow resistance and adrenergic mechanisms. Arch. Ophthal. 64, 839–848 (1960).
Sears, M.L., Gillis, C.N.: Mydriasis and the increase in outflow of the aqueous humor from the rabbit eye after cervical ganglionectomy in relation to the release of norepinephrine from the iris. Biochem. Pharmacol. 16, 777–782 (1967).
Sedvall, G.C., Kopin, I.J.: Influence of sympathetic denervation and nerve impulse activity of tyrosine hydroxylase in the rat submaxillary gland. Biochem. Pharmacol. 16, 39–46 (1967).
Senoh, S., Creveling, C.R., Udenfriend, S., Witkop, B.: Chemical, enzymatic and metabolic studies on the mechanism of oxydation of dopamine. J. Amer. chem. Soc. 81, 6236 to 6240 (1959a).
Senoh, S., Witkop, B.: Non-enzymatic conversions of dopamine to norepinephrine and trihydroxyphenethylamines. J. Amer. chem. Soc. 81, 6222–6231 (1959).
Senoh, S., Witkop, B., Creveling, C. R., Udenfriend, S.: 2,4,5-Trihydroxyphenethylamine, a new metaboliteof 3,4-dihydroxyphenethylamine. J. Amer. chem. Soc. 81, 1768–1769 (1959).
Sidman, R.L., Perkins, M., Weiner, N.: Noradrenaline and adrenaline content of adipose tissue. Nature (Lond.) 193, 36–37 (1962).
Sjöqvist, F., Taylor, P.W., Jr., Titus, E.: The effect of immunosympathectomy on the retention and metabolism of noradrenaline. Acta physiol. scand. 69, 13–22 (1967).
Sjöqvist, F., Titus, E., Michaelson, I.A., Taylor, Jr., P.W., Richardson, K.C.: Uptake and meta-bolism of d, l-norepinephrine–7-H3 in tissues of immunosympathectomized mice and rats. Life Sci. 4, 1125–1133 (1965).
Sjöstrand, N. O.: The adrenergic innervation of the vas deferens and the accessory male genital glands. Acta physiol. scand. 65, Suppl. 257, 1–82 (1965).
Smith, C.B.: Relaxation of the nictitating membrane of the spinal cat by sympathomimetic amines. J. Pharmacol, exp. Ther. 142, 163–170 (1963).
Smith, C.B.: Trendelenburg, U., Langer, S.Z., Tsai, T.H.: The relation of retention of norepine-phrine 3 to the norepinephrine content of the nictitating membrane of the spinal cat during development of denervation supersensitivity. J. Pharmacol, exp. Ther. 151, 87–94 (1966).
Snipes, R.L., Thoenen, H., Tranzer, J.P.: Fine structural localization of exogenous 5-HT in vesicles of adrenergic nerve terminals. Experientia (Basel) 24, 1026–1027 (1968).
Snyder, S.H., Axelrod, J., Wurtman, R. J., Fischer, J.E.: Control of 5-hydroxytryptophan decarboxylase activity in the rat pineal gland by sympathetic nerves. J. Pharmacol, exp. Ther. 147, 371–375 (1965 a).
Snyder, S.H., Fischer, J., Axelrod, J.: Evidence for the presence of monoamine oxidase in sympathetic nerve endings. Biochem. Pharmacol. 14, 363–365 (1965b).
Sourkes, T.L.: Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanine. Arch. Biochem. 51, 444–456 (1954).
Stern, D.N., Maling, H.M., Altland, P.D., Brodie, B.B.: Exhaustion and metabolic changes during exercise in adrenalectomized and chemically sympathectomized rats. Pharmacologist 6, 185 (1964).
Stone, C.A., Porter, C.C., Stavorski, J.M., Ludden, C.T., Totaro, J.A.: Antagonism of certain effects of catecholamine-depleting agents by antidepressant and related drugs. J. Pharmacol, exp. Ther. 144, 196–204 (1964).
Stone, C.A., Stavorski, J.M., Ludden, C.T., Wenger, H.C., Ross, C. A., Totaro, J. A., Porter, C.C.: Comparison of some pharmacologic effects of certain 6-substituted dopamine derivatives with reserpine, guanethidine and metaraminol. J. Pharmacol, exp. Ther. 142, 147–156 (1963).
Strömblad, B. C. R.: Supersensitivity and amine oxidase activity in denervated salivary glands. Acta physiol. scand. 36, 137–153 (1956).
Strömblad, B. C. R., Nickerson, M.: Accumulation of epinephrine and norepinephrine by some rat tissues. J. Pharmacol, exp. Ther. 134, 154–159 (1961).
Thoenen, H., Haefely, W., Gey, K.F., Hürlimann, A.: Die Wirkung der Vorbehandlung mit 5-Hydroxy-DOPA auf die postganglionäre sympathische Transmission der Katze. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 257, 342–343 (1967a).
Thoenen, H., Haefely, W., Gey, K.F., Hürlimann, A.: Diminished Effect Of Sympathetic Nerve Stimulation In Cats Pretreated With 5-Hydroxydopa; Formation And Liberation Of False Adrenergic Transmitters. Naunyn-Schmiedeberg’S Arch. Pharmak. Exp. Path. 259,17–33 (1967B).
Thoenen, H., Huerlimann, A., Haefely, W.: Mode of action of imipramine and 5-(3’methylaminopro pyliden)-dibenzo[a,e]cyclohepta[l,3,5]trien hydrochloride (Ro 4–6011), a new antidepressant drug, on peripheral adrenergic mechanisms. J. Pharmacol, exp. Ther. 144, 405–414 (1964).
Thoenen, H., Huerlimann, A., Haefely, W.: Mechanism Of Amphetamine Accumulation In The Isolated Perfused Heart Of The Rat. J. Pharm. Pharmacol. 20, 1–11 (1968).
Thoenen, H., Tranzer, J.P.: Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 261, 271–288 (1968).
Thoenen, H.,Haeusler, G.: Chemical sympathectomy with 6-hydroxydopamine. In: New aspectsof storage and release mechanisms of catecholamines. Berlin-Heidelberg-New York: Springer 1970.
Hompson, J.H., Campbell, L.B.: Bowel 5-hydroxytryptamine in the immunosympathecto-mised mouse. J. Pharm. Pharmacol. 18, 753–755 (1966).
Tranzer, J. P., Thoenen, H.: Ultramorphologische Veränderungen der sympathischen Nervenendigungen der Katze nach Vorbehandlung mit 5-und 6-Hydroxy-Dopamin. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 257, 343–344 (1967a).
Tranzer, J. P., Thoenen, H.: Electronmicroscopic Localization Of 5-Hydroxy Dopamine (3,4,5-Trihydroxy-Phenylethylamine), A New ‘False’ Sympathetic Transmitter. Experientia (Basel) 23, 743–745 (1967B).
Tranzer, J. P., Thoenen, H.: Significance Of ‘Empty Vesicles’ In Postganglionic Sympathetic Nerve Terminals. Experientia (Basel) 23, 123–124 (1967 C).
Tranzer, J. P., Thoenen, H.: An Electron Microscopic Study Of Selective, Acute Degeneration Of Sympathetic Nerveterminals After Administration Of 6-Hydroxydopamine. Experientia (Basel) 24, 155–156 (1968A).
Tranzer, J. P., Thoenen, H.: Various Types Of Amine-Storing Vesicles In Peripheral Adrenergic Nerve Terminal. Experientia (Basel) 24, 484–486 (1968B).
Tranzer, J. P., Thoenen, H., Snipes, R.L., Richards, J.G.: Recent developments on the ultrastructural aspect ofadrenergic nerve endings in various experimental conditions. Progr. Brain Res. 31, 33–46 (1969).
Trendelenburg, U.: The supersensitivity caused by cocaine. J. Pharmacol, exp. Ther. 125, 55–63 (1959).
Trendelenburg, U.: Time Course Of Changes In Sensitivity After Denervation Of The Nictitating Membrane Of The Spinal Cat. J. Pharmacol, Exp. Ther. 142, 335–342 (1963A).
Trendelenburg, U.: Supersensitivity And Subsensitivity To Sympathomimetic Amines. Pharmacol. Rev. 15, 225–276 (1963B).
Trendelenburg, U., Drasköczy, P. R., Plijchino, S.: The density of adrenergic innervation of the cats nictitating membrane as a factor influencing the sensitivity of the isolated preparation to 1-norepinephrine. J. Pharmacol, exp. Ther. 166, 14–25 (1969).
Trendelenburg, U., Muskus, A., Fleming, W. W., Gomez Alonso De La Sierra, B.: Effect of cocaine, denervation and decentralization on the response of the nictitating membrane to various sympathomimetic amines. J. Pharmacol, exp. Ther. 138, 181–193 (1962).
Trendelenburg, U., Weiner, N.: Sensitivity of the nictitating membrane after various procedures and agents. J. Pharmacol, exp. Ther. 136, 152–161 (1962).
Tsai, T.H., Denham, S., Mcgrath, W.R.: Sensitivity of the isolated nictitating membrane of the cat to norepinephrine and acetylcholine after various procedures and agents. J. Pharmacol, exp. Ther. 164, 146–157 (1968).
Udenfriend, S., Zaltzman-Nirenberg, P., Nagatsu, T.: Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem. Pharmacol. 14, 837–845 (1965).
Ungerstedt, U.: 6-Hydroxydopamine induced degeneration of central monoamine neurons. Europ. J. Pharmacol. 5, 107–110 (1968).
Uretsky, N.J., Iversen, L.L.: Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain. Nature (Lond.) 221, 557–559 (1969).
Uretsky, N.J., Iversen, L.L.: Effects Of 6-Hydroxydopamine On Catecholamine Containing Neurones In The Rat Brain. J. Neurochem. 17, 269–278 (1970).
Van Orden, L.S., Iii, Bensch, K.G., Langer, S.Z., Trendelenburg, U.: Histochemical and fine structural aspects of the onset of denervation supersensitivity in the nictitating membrane of the spinal cat. J. Pharmacol, exp. Ther. 157, 274–283 (1967).
Van Orden, L.S., Bloom, F.E., Barrnett, R. J., Giarman, N.J.: Histochemical and functional relationships of catecholamines in adrenergic nerve endings: I. Participation of granular vesicles. J. Pharmacol, exp. Ther. 154, 185–199 (1966).
Varon, S., Nomura, J., Shooter, E.M.: Subunit structure of a high-molecular-weight form of the nerve growth factor from mouse submaxillary gland. Proc. nat. Acad. Sci. (Wash.) 57, 1782–1789 (1967a).
Varon, S., Nomura, J., Shooter, E.M.: The Isolation Of The Mouse Nerve Growth Factor Protein In A High Molecular Weightform. Biochemistry 6, 2202–2209 (1967B).
Vogt, M.: Sources of noradrenaline in the ‘immunosympathectomized’ rat. Nature (Lond.) 204, 1315–1316 (1964).
Vogt, M.: Release Of Medullary Amines From The Isolated Perfused Adrenal Gland Of The Dog. Brit. J. Pharmacol. 24, 561–565 (1965).
Waltman, S., Sears, M.: Catechol-O-methyl transferase and monoamine oxidase activity in the ocular tissues of albino rabbits. Invest. Ophthal. 3, 601–605 (1964).
Wegmann, A., Chiba, C., Chrysohou, A., Bing, J.R.: Catecholamines in homologous heart grafts. Proc. Soc. exp. Biol. (N.Y.) 109, 543–545 (1962).
Weiner, N., Langer, S.Z., Trendelenburg, U.: Demonstration by the histochemical fluorescence method of the prolonged disappearance of catecholamines from the denervated nictitating membrane of the cat. J. Pharmacol, exp. Ther. 157, 284–289 (1967).
Whitby, L.G., Axelrod, J., Weil-Malherbe, H.: The fate of H3-norepinephrine in animals. J. Pharmacol, exp. Ther. 132, 193–201 (1961).
Wolfe, D.E., Potter, L.T., Richardson, K.C., Axelrod, J.: Localizing tritiated norepinephrine in sympathetic axons by electon microscopic autoradiography. Science 138, 440–442 (1962).
Wolinsky, H., Glagov, S.: Nature and species differences in the medial distribution of aortic vasa vasorum in mammals. Circulat. Res. 20, 409–421 (1967).
Wurtman, R. J., Kopin, I. J., Horst, D., Fischer, J.E.: Epinephrine and organ blood flow: effects of hyperthyroidism, cocaine, and sympathetic denervation. Amer. J. Physiol. 207, 1247–1250 (1964).
Wurtman, R. J., Sheix, H.M., Axelrod, J., Laren, F.: Incorporation of 14C-tryptophan into 14C-protein by cultured rat pineals: Stimulation by 1-norepinephrine. Proc. nat. Acad. Sci. (Wash.) 62, 749–755 (1969).
Zaimis, E.: The immunosympathectomized animal: a valuable tool in physiological and pharmacological research. J. Physiol. (Lond.) 177, 35P–37P (1965).
Zaimis, E., Berk, L., Callingham, B.: Morphological, biochemical, and functional changes in the sympathetic nervous system of rats treated with nerve growth factor-antiserum. Nature (Lond.) 206, 1220–1222 (1965).
Zeller, E.A.: Amine oxidase inhibitors. Ann. N.Y. Acad. Sci. 80, 551–1045 (1959).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Thoenen, H. (1972). Surgical, Immunological and Chemical Sympathectomy Their Application in the Investigation of the Physiology and Pharmacology of the Sympathetic Nervous System. In: Blaschko, H., Muscholl, E. (eds) Catecholamines. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65249-3_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-65249-3_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65251-6
Online ISBN: 978-3-642-65249-3
eBook Packages: Springer Book Archive